Related Experiment Video
Updated: May 9, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Cardiovascular effects of calcium supplements
1Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand. i.reid@auckland.ac.nz
Calcium supplements offer minimal bone protection and may significantly increase risks of heart attack and stroke. These non-skeletal risks appear to outweigh any skeletal benefits, making them potentially unnecessary for osteoporosis treatment.
Area of Science:
- Nutritional Science
- Cardiovascular Health
- Bone Metabolism
Background:
- Calcium supplements are widely used to prevent bone loss and fractures.
- Evidence for reduced fracture incidence with calcium is limited and of questionable significance.
- Concerns exist regarding potential cardiovascular risks associated with calcium supplementation.
Purpose of the Study:
- To evaluate the overall safety and efficacy of calcium supplements.
- To assess the impact of calcium on fracture incidence and cardiovascular events.
- To determine if calcium supplementation is necessary for osteoporosis management.
Main Methods:
- Meta-analysis of randomized, placebo-controlled trials of calcium supplements.
- Pre-specified analyses to assess cardiovascular risks, including myocardial infarction and stroke.
- Evaluation of skeletal benefits in terms of fracture reduction.
Main Results:
- Calcium supplements showed a borderline 10% decrease in fracture incidence.
- A significant increase in myocardial infarction (27%-31%) and stroke (12%-20%) risk was observed.
- Co-administration with vitamin D did not mitigate these adverse cardiovascular effects.
Conclusions:
- The non-skeletal risks of calcium supplements, particularly cardiovascular events, appear to outweigh skeletal benefits.
- Calcium supplements may not be necessary for osteoporosis treatment, especially when other therapies are used.
- Further research into the mechanisms linking calcium supplements to cardiovascular disease is warranted.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
